Oslo, Norway, September 1, 2022 – Genetic Analysis AS (“GA” or “the Company”) has appointed Sedermera Corporate Finance as the Company’s liquidity provider. The assignment will commence on the 5 September 2022 and Sedermera will continuously place trading items on both bid and ask side in the order book for the Genetic Analysis share and ensure that a predetermined spread is maintained in the share. The purpose of the liquidity providing is to promote good liquidity and ensure a low spread between the bid and ask price in current trading.
Please read the full press release:
The press release is also translated and available in Swedish language: